Whitehawk Therapeutics (WHWK) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.73% |
| Dec 31, 2025 | 35.59% |
| Sep 30, 2025 | -46.63% |
| Jun 30, 2025 | -58.58% |
| Mar 31, 2025 | 120.79% |
| Dec 31, 2024 | 17.43% |
| Sep 30, 2024 | -17.33% |
| Jun 30, 2024 | -19.14% |
| Mar 31, 2024 | 0.18% |
| Dec 31, 2023 | 0.92% |
| Sep 30, 2023 | 92.81% |
| Jun 30, 2023 | -9.12% |
| Mar 31, 2023 | 5.22% |
| Dec 31, 2022 | -83.82% |
| Sep 30, 2022 | 43.10% |
| Jun 30, 2022 | -11.92% |
| Mar 31, 2022 | -20.79% |
| Dec 31, 2021 | -112.28% |
| Sep 30, 2021 | 248.01% |
| Jun 30, 2021 | 3.91% |
| Mar 31, 2021 | 36.10% |
| Dec 31, 2020 | -206.20% |
| Sep 30, 2020 | -428.59% |
| Jun 30, 2020 | 279.02% |
| Mar 31, 2020 | -194.25% |
| Dec 31, 2019 | -229.09% |
| Sep 30, 2019 | -389.23% |
| Jun 30, 2019 | -425.42% |
| Mar 31, 2019 | -645.19% |
| Dec 31, 2018 | -334.22% |
| Sep 30, 2018 | 37.76% |
| Jun 30, 2018 | 411.50% |
| Mar 31, 2018 | -409.09% |
| Dec 31, 2017 | -466.27% |
| Sep 30, 2017 | -300.10% |
| Jun 30, 2017 | -237.88% |
| Mar 31, 2017 | 343.81% |
| Dec 31, 2016 | 173.24% |
| Sep 30, 2016 | -148.61% |
| Jun 30, 2016 | -203.63% |
| Mar 31, 2016 | -345.74% |
| Dec 31, 2015 | -13.03% |
| Sep 30, 2015 | -1.76% |